Industry partners launch Biosimilars Forum

A coalition of 11 companies launched the Biosimilars Forum, a not-for-profit group dedicated to increasing patient access to biosimilars in the U.S.

Founding members include Actavis plc (NYSE:ACT), Amgen Inc. (NASDAQ:AMGN), Boehringer Ingelheim GmbH (Ingelheim, Germany), Coherus BioSciences Inc. (NASDAQ:CHRS), the EMD Serono subsidiary of Merck KGaA (Xetra:MRK), Hospira Inc. (NYSE:HSP), Merck & Co. Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), the Sandoz unit of Novartis AG (NYSE:NVS; SIX:NOVN), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Samsung Bioepis Co. Ltd., a JV between Biogen Inc. (NASDAQ:BIIB) and Samsung Group (Seoul, South Korea). ...